NUS Non Current Liabilities Total vs Total Current Liabilities Analysis

NUS Stock

USD 13.59 0.30 2.16%

Nu Skin financial indicator trend analysis is infinitely more than just investigating Nu Skin Enterprises recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nu Skin Enterprises is a good investment. Please check the relationship between Nu Skin Non Current Liabilities Total and its Total Current Liabilities accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

Non Current Liabilities Total vs Total Current Liabilities

Non Current Liabilities Total vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nu Skin Enterprises Non Current Liabilities Total account and Total Current Liabilities. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Nu Skin's Non Current Liabilities Total and Total Current Liabilities is 0.17. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Nu Skin Enterprises, assuming nothing else is changed. The correlation between historical values of Nu Skin's Non Current Liabilities Total and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Nu Skin Enterprises are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Non Current Liabilities Total i.e., Nu Skin's Non Current Liabilities Total and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.17

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Non Current Liabilities Total

Total Current Liabilities

Total Current Liabilities is an item on Nu Skin balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Nu Skin Enterprises are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most indicators from Nu Skin's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nu Skin Enterprises current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

At this time, Nu Skin's Selling General Administrative is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.37 in 2024, despite the fact that Tax Provision is likely to grow to (16.1 M).

	2021	2022	2023	2024 (projected)
Gross Profit	2.0B	1.6B	1.4B	1.4B
Total Revenue	2.7B	2.2B	2.0B	1.8B

Gross Profit Total Revenue

Nu Skin fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Short Term Debt	Property Plant And Equipment Gross	Good Will	Common Stock Total Equity	Intangible Assets
Total Assets		0.7	0.77	0.96	0.94	0.22	0.96	0.76	0.72	0.95	0.51	0.73	0.62	-0.87	0.61	0.93	0.32	-0.76	0.97	0.91	0.56	0.05	0.57	0.56	0.07	-0.19
Other Current Liab	0.7		0.98	0.66	0.53	-0.37	0.5	0.86	0.88	0.45	0.3	0.89	0.5	-0.38	0.08	0.71	0.53	-0.26	0.69	0.91	0.05	0.24	0.21	0.03	-0.2	-0.18
Total Current Liabilities	0.77	0.98		0.73	0.62	-0.29	0.6	0.89	0.91	0.55	0.32	0.91	0.52	-0.49	0.17	0.78	0.47	-0.37	0.77	0.95	0.15	0.31	0.27	0.11	-0.18	-0.2
Total Stockholder Equity	0.96	0.66	0.73		0.89	0.15	0.91	0.66	0.64	0.9	0.56	0.65	0.54	-0.8	0.51	0.91	0.49	-0.64	0.87	0.89	0.44	-0.01	0.5	0.46	0.0	-0.25
Property Plant And Equipment Net	0.94	0.53	0.62	0.89		0.36	0.96	0.57	0.55	0.96	0.41	0.55	0.48	-0.83	0.65	0.89	0.08	-0.8	0.92	0.76	0.63	0.12	0.58	0.64	0.03	-0.24
Net Debt	0.22	-0.37	-0.29	0.15	0.36		0.38	-0.18	-0.34	0.47	-0.02	-0.34	0.43	-0.59	0.85	0.18	-0.41	-0.72	0.26	-0.14	0.88	-0.16	0.75	0.71	0.66	0.14
Retained Earnings	0.96	0.5	0.6	0.91	0.96	0.38		0.61	0.57	0.99	0.53	0.57	0.5	-0.91	0.69	0.88	0.15	-0.85	0.94	0.77	0.65	0.03	0.57	0.64	0.11	-0.25
Accounts Payable	0.76	0.86	0.89	0.66	0.57	-0.18	0.61		0.88	0.58	0.2	0.88	0.62	-0.56	0.3	0.66	0.34	-0.44	0.79	0.88	0.25	0.0	0.28	0.27	-0.08	-0.02
Cash	0.72	0.88	0.91	0.64	0.55	-0.34	0.57	0.88		0.51	0.49	1.0	0.45	-0.49	0.19	0.6	0.36	-0.37	0.74	0.89	0.13	0.14	0.21	0.03	-0.24	-0.21
Non Current Assets Total	0.95	0.45	0.55	0.9	0.96	0.47	0.99	0.58	0.51		0.47	0.51	0.59	-0.92	0.76	0.85	0.12	-0.86	0.93	0.73	0.71	-0.05	0.65	0.73	0.21	-0.13
Non Currrent Assets Other	0.51	0.3	0.32	0.56	0.41	-0.02	0.53	0.2	0.49	0.47		0.48	0.14	-0.5	0.29	0.4	0.46	-0.39	0.43	0.47	0.18	-0.17	0.23	-0.06	-0.07	-0.49
Cash And Short Term Investments	0.73	0.89	0.91	0.65	0.55	-0.34	0.57	0.88	1.0	0.51	0.48		0.46	-0.49	0.19	0.61	0.37	-0.36	0.74	0.89	0.13	0.13	0.21	0.03	-0.24	-0.2
Net Receivables	0.62	0.5	0.52	0.54	0.48	0.43	0.5	0.62	0.45	0.59	0.14	0.46		-0.67	0.71	0.48	0.18	-0.61	0.64	0.56	0.68	-0.24	0.83	0.54	0.58	0.34
Common Stock Shares Outstanding	-0.87	-0.38	-0.49	-0.8	-0.83	-0.59	-0.91	-0.56	-0.49	-0.92	-0.5	-0.49	-0.67		-0.88	-0.75	-0.09	0.95	-0.87	-0.66	-0.83	0.08	-0.76	-0.65	-0.34	0.18
Non Current Liabilities Total	0.61	0.08	0.17	0.51	0.65	0.85	0.69	0.3	0.19	0.76	0.29	0.19	0.71	-0.88		0.49	-0.21	-0.94	0.66	0.33	0.98	-0.19	0.88	0.75	0.54	0.03
Inventory	0.93	0.71	0.78	0.91	0.89	0.18	0.88	0.66	0.6	0.85	0.4	0.61	0.48	-0.75	0.49		0.38	-0.68	0.88	0.88	0.47	0.27	0.46	0.5	-0.03	-0.3
Other Current Assets	0.32	0.53	0.47	0.49	0.08	-0.41	0.15	0.34	0.36	0.12	0.46	0.37	0.18	-0.09	-0.21	0.38		0.15	0.15	0.52	-0.29	-0.11	-0.02	-0.33	-0.08	-0.24
Other Stockholder Equity	-0.76	-0.26	-0.37	-0.64	-0.8	-0.72	-0.85	-0.44	-0.37	-0.86	-0.39	-0.36	-0.61	0.95	-0.94	-0.68	0.15		-0.81	-0.51	-0.93	-0.02	-0.79	-0.7	-0.36	0.18
Total Liab	0.97	0.69	0.77	0.87	0.92	0.26	0.94	0.79	0.74	0.93	0.43	0.74	0.64	-0.87	0.66	0.88	0.15	-0.81		0.87	0.63	0.09	0.59	0.61	0.12	-0.12
Total Current Assets	0.91	0.91	0.95	0.89	0.76	-0.14	0.77	0.88	0.89	0.73	0.47	0.89	0.56	-0.66	0.33	0.88	0.52	-0.51	0.87		0.28	0.16	0.37	0.25	-0.12	-0.23
Short Long Term Debt Total	0.56	0.05	0.15	0.44	0.63	0.88	0.65	0.25	0.13	0.71	0.18	0.13	0.68	-0.83	0.98	0.47	-0.29	-0.93	0.63	0.28		-0.06	0.89	0.76	0.57	0.06
Short Term Debt	0.05	0.24	0.31	-0.01	0.12	-0.16	0.03	0.0	0.14	-0.05	-0.17	0.13	-0.24	0.08	-0.19	0.27	-0.11	-0.02	0.09	0.16	-0.06		-0.08	-0.14	-0.2	-0.18
Property Plant And Equipment Gross	0.57	0.21	0.27	0.5	0.58	0.75	0.57	0.28	0.21	0.65	0.23	0.21	0.83	-0.76	0.88	0.46	-0.02	-0.79	0.59	0.37	0.89	-0.08		0.57	0.7	0.15
Good Will	0.56	0.03	0.11	0.46	0.64	0.71	0.64	0.27	0.03	0.73	-0.06	0.03	0.54	-0.65	0.75	0.5	-0.33	-0.7	0.61	0.25	0.76	-0.14	0.57		0.41	0.34
Common Stock Total Equity	0.07	-0.2	-0.18	0.0	0.03	0.66	0.11	-0.08	-0.24	0.21	-0.07	-0.24	0.58	-0.34	0.54	-0.03	-0.08	-0.36	0.12	-0.12	0.57	-0.2	0.7	0.41		0.55
Intangible Assets	-0.19	-0.18	-0.2	-0.25	-0.24	0.14	-0.25	-0.02	-0.21	-0.13	-0.49	-0.2	0.34	0.18	0.03	-0.3	-0.24	0.18	-0.12	-0.23	0.06	-0.18	0.15	0.34	0.55

Click cells to compare fundamentals

Nu Skin Account Relationship Matchups

Nu Skin fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.8B	2.0B	1.9B	1.8B	1.8B	1.2B
Other Current Liab	270.1M	366.6M	339.1M	253.2M	216.1M	214.0M
Total Current Liabilities	356.8M	542.9M	529.7M	359.2M	328.9M	305.0M
Total Stockholder Equity	875.3M	894.3M	912.8M	897.3M	822.0M	572.2M
Property Plant And Equipment Net	597.9M	653.5M	574.6M	543.5M	523.1M	263.7M
Net Debt	132.0M	97.7M	125.4M	214.3M	351.3M	368.8M
Retained Earnings	1.7B	1.8B	1.9B	1.9B	1.9B	1.0B
Accounts Payable	39.0M	66.2M	50.0M	54.0M	43.5M	34.4M
Cash	335.6M	402.7M	339.6M	264.7M	256.1M	248.8M
Non Current Assets Total	1.0B	1.1B	1.0B	1.1B	1.1B	607.7M
Non Currrent Assets Other	154.0M	50.6M	113.1M	115.2M	110.0M	104.5M
Cash And Short Term Investments	344.0M	423.9M	354.8M	278.5M	267.8M	256.4M
Net Receivables	50.4M	63.4M	41.3M	47.4M	72.9M	76.5M
Common Stock Shares Outstanding	55.9M	52.8M	51.4M	50.5M	49.9M	54.3M
Liabilities And Stockholders Equity	1.8B	2.0B	1.9B	1.8B	1.8B	1.2B
Non Current Liabilities Total	537.0M	519.9M	464.0M	564.4M	655.6M	688.4M
Inventory	275.9M	314.4M	399.9M	346.2M	280.0M	187.9M
Other Current Assets	69.9M	14.7M	76.9M	87.8M	71.0M	65.8M
Other Stockholder Equity	(767.3M)	(881.8M)	(925.2M)	(955.8M)	(948.6M)	(901.2M)
Total Liab	893.7M	1.1B	993.7M	923.7M	984.5M	586.6M
Total Current Assets	740.2M	903.2M	873.0M	759.9M	691.6M	551.1M
Short Long Term Debt Total	467.7M	500.4M	465.0M	479.0M	607.3M	637.7M
Short Term Debt	27.5M	75.0M	107.5M	25M	48.9M	51.8M
Property Plant And Equipment Gross	597.9M	653.5M	453.7M	444.8M	897.6M	942.5M
Accumulated Other Comprehensive Income	(85.3M)	(64.8M)	(73.9M)	(86.5M)	(100.0M)	(105.0M)
Intangible Assets	80.3M	89.5M	77.0M	66.7M	105.3M	84.0M
Other Liab	96.8M	102.3M	106.5M	98.3M	113.0M	72.4M
Other Assets	154.0M	293.2M	175.5M	244.4M	281.1M	152.1M
Long Term Debt	334.5M	305.4M	268.8M	377.5M	478.0M	501.9M
Property Plant Equipment	453.6M	468.2M	453.7M	444.8M	511.5M	275.1M
Current Deferred Revenue	20.2M	35.1M	33.1M	27.1M	20.4M	17.9M
Short Term Investments	8.4M	21.2M	15.2M	13.8M	11.8M	13.7M
Treasury Stock	(1.3B)	(1.3B)	(1.5B)	(1.5B)	(1.4B)	(1.3B)
Net Tangible Assets	875.3M	894.3M	912.8M	897.3M	1.0B	829.4M
Retained Earnings Total Equity	1.7B	1.8B	1.9B	1.9B	2.2B	1.6B
Long Term Debt Total	334.5M	313.1M	274.1M	389.6M	448.0M	321.7M
Capital Surpluse	557.5M	579.8M	601.7M	613.3M	705.3M	500.0M
Non Current Liabilities Other	105.7M	112.3M	88.8M	76.5M	9.0M	8.5M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Nu Skin Enterprises is a strong investment it is important to analyze Nu Skin's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nu Skin's future performance. For an informed investment choice regarding NUS Stock, refer to the following important reports:

How To Invest In NUS

Details

Is NUS Stock a good investment?

Details

What is Nu Skin's Net Worth?

Details

Largest Personal Care Products Companies

View

Largest Household & Personal Products Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for NUS Stock analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.

	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Commodity Directory Find actively traded commodities issued by global exchanges
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon

Is Nu Skin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nu Skin. If investors know NUS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nu Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.88)

Dividend Share

1.23

Earnings Share

(0.07)

Revenue Per Share

38.341

Quarterly Revenue Growth

(0.13)

The market value of Nu Skin Enterprises is measured differently than its book value, which is the value of NUS that is recorded on the company's balance sheet. Investors also form their own opinion of Nu Skin's value that differs from its market value or its book value, called intrinsic value, which is Nu Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nu Skin's market value can be influenced by many factors that don't directly affect Nu Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nu Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nu Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nu Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

NUS Non Current Liabilities Total vs Total Current Liabilities Analysis

Non Current Liabilities Total vs Total Current Liabilities

Non Current Liabilities Total vs Total Current Liabilities Correlation Analysis

Correlation Coefficient

Non Current Liabilities Total

Total Current Liabilities

Nu Skin fundamental ratios Correlations

Nu Skin Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nu Skin fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for NUS Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Assets Total	+ 0.99	Retained Earnings
Total Current Liabilities	+ 0.98	Other Current Liab
Short Long Term Debt Total	+ 0.98	Non Current Liabilities Total
Total Liab	+ 0.97	Total Assets
Total Stockholder Equity	+ 0.96	Total Assets

Other Stockholder Equity	- 0.94	Non Current Liabilities Total
Short Long Term Debt Total	- 0.93	Other Stockholder Equity
Common Stock Shares Outstanding	- 0.92	Non Current Assets Total
Common Stock Shares Outstanding	- 0.91	Retained Earnings
Non Current Liabilities Total	- 0.88	Common Stock Shares Outstanding
Total Liab	- 0.87	Common Stock Shares Outstanding